Postdoctoral Research Assistant

About the Role

Applications are invited for a Postdoctoral Researcher to join the Translational Lymphoma Research group of Professor Jessica Okosun. Our lab aims to understand the biological mechanisms that underpin disease initiation, progression and the different clinical behaviours of specific B- and T-cell non-Hodgkin’s lymphomas by investigating intra-tumour heterogeneity, clonal evolution, biomarkers of response and resistance to therapies and developing methodologies to study lymphoma cell populations (Okosun et al, 2014; 2016, Nature Genetics; Araf et al, Leukemia 2018; Poynton et al, Blood Adv 2023; Coulter et al, J Mol Diagn 2024). The successful postdoc will investigate pre- and post-treatment tumour and immune heterogeneity and spatial dynamics using patient samples and employing a combination of multi-modal single cell techniques (scRNA-seq, scATAC-seq).

Informal enquiries are highly encouraged - [email protected]

About You

We are seeking highly-motivated researchers with a submitted PhD or PhD in molecular biology, genomics, immunology, bioinformatics or a relevant discipline with strong technical expertise in multi-omics approaches. Demonstrable experience with flow cytometry, single cell analytics and bioinformatics would be highly desirable.

About the Institute

The Barts Cancer Institute (BCI) is a Cancer Research UK Centre of Excellence whose work aims to transform the lives of those with and at risk of cancer through innovative research in the laboratory, in patients and in populations. BCI is also a partner in the CRUK City of London Major Centre (together with UCL, Kings and the Francis Crick Institute) which is a Centre of Excellence in Biotherapeutics. BCI is committed in supporting and developing future cancer researchers through its extensive postgraduate training.

About Queen Mary

At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.

Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.

Our reformer heritage informs our conviction that great ideas can and should come from anywhere. It’s an approach that has brought results across the globe, from the communities of east London to the favelas of Rio de Janeiro.

We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.

Benefits

In return, we offer 30 days’ leave per annum, access to a pension scheme, a season ticket loan scheme and competitive salaries. We also offer enhanced family friendly leave, and an on-site nursery at the Mile End campus. You will also work with a friendly team, with personal development opportunities.

The post is based at the Centre for Haemato-Oncology, BCI. It is full time, fixed term for 12 months in the first instance (potential for extension), with an expected start date of July 2024. The starting salary will be Grade 4 (Sp 29-33), in the range of £40,223 - £44,722 per annum, inclusive of London Allowance.

Queen Mary’s commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability. We are open to considering applications from candidates wishing to work flexibly.